We are live on
!
Find out more
CRISPR Therapeutics
CRSP
CRSP
479 hedge funds and large institutions have $4.03B invested in CRISPR Therapeutics in 2025 Q4 according to their latest regulatory filings, with 95 funds opening new positions, 151 increasing their positions, 127 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
83% more first-time investments, than exits
New positions opened: 95 | Existing positions closed: 52
35% more call options, than puts
Call options by funds: $233M | Put options by funds: $172M
19% more repeat investments, than reductions
Existing positions increased: 151 | Existing positions reduced: 127
9% more funds holding
Funds holding: 440 → 479 (+39)
0.82% more ownership
Funds ownership: 79.43% → 80.26% (+0.82%)
14% less capital invested
Capital invested by funds: $4.68B → $4.03B (-$657M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
479
Holders Change
+39
Holders Change %
+8.86%
% of All Funds
5.83%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.07%
New
95
Increased
151
Reduced
127
Closed
52
Calls
$233M
Puts
$172M
Net Calls
+$61M
Net Calls Change
+$25M
Top Buyers
| 1 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
+$58M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$44M |
| 3 |
Squarepoint
New York
|
+$34.8M |
| 4 |
BlackRock
New York
|
+$27.4M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$14.6M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$43.8M |
| 2 |
Two Sigma Investments
New York
|
-$34.4M |
| 3 |
Two Sigma Advisers
New York
|
-$24.6M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$18M |
| 5 |
State Street
Boston,
Massachusetts
|
-$15.2M |